Related Experiment Video

Updated: Oct 3, 2025

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
11:52

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro

Published on: April 21, 2023

3.3K

Nanoparticle, a promising therapeutic strategy for the treatment of infective endocarditis

Qi Tong1, Tao Li1, Lu Jiang2

  • 1Department of Cardiovascular Surgery, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University; Chengdu-China.

Anatolian Journal of Cardiology
|February 22, 2022
PubMed

Insights

Nanoparticles offer a promising solution for treating infective endocarditis (IE), a challenging biofilm-related disease. This review highlights their potential to overcome antibiotic resistance and improve patient outcomes.

Area of Science:

  • Biomedical Engineering
  • Infectious Diseases
  • Materials Science

Background:

  • Infective endocarditis (IE) is a serious biofilm-related disease affecting heart valves and endocardium.
  • Antimicrobial treatment of IE faces challenges like drug resistance, high dosages, side effects, and poor prognosis.

Purpose of the Study:

  • To review recent advancements in nanoparticle-based antimicrobial strategies for IE.
  • To explore the potential of nanoparticles in combating drug-resistant bacteria in IE biofilms.

Main Methods:

  • Literature review of studies on nanoparticles in antimicrobial therapy.
  • Analysis of nanoparticle properties and their efficacy against IE pathogens.
  • Evaluation of nanoparticles as novel drug delivery systems (NDDS) for IE treatment.

Main Results:

  • Nanoparticles show potential in enhancing antimicrobial activity and drug bioavailability.
  • They can minimize drug administration frequency and reduce associated side effects.
  • Nanoparticles demonstrate efficacy against drug-resistant bacteria within biofilms.

Conclusions:

  • Nanoparticles represent a promising alternative strategy for IE treatment.
  • Further research into nanoparticle applications could revolutionize IE therapy.
  • Nanotechnology offers a viable approach to address limitations in current IE antimicrobial treatments.

More Related Videos

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.5K
Harmonic Nanoparticles for Regenerative Research09:23

Harmonic Nanoparticles for Regenerative Research

Published on: May 1, 2014

11.9K

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
32
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
62
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
48
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
35
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
27